|
That is a good question for your husband's hematologist/oncologist. From general reading, it seems that cellularity is used as a diagnostic/classification tool and in that case, hypocellularity (too few) is separated from hypercellularity/normocelluarity as a group. However, I've read in at least one study that cellularity is not a prognostic indicator in MDS. Let me note that I'm a computer geek, not a medical person, so take anything I say with a grain of salt!
__________________
Karen, age 62, dx MDS RAEB-2 1/8/10: pancytopenia WBC 2.7k/Hgb 7.4/Hct 22.1/Plt 19k; complex cytogenetics -3,del(5)(q14q33),-6,+8,+mar,17% blasts. MUD BMT Johns Hopkins 11/30/10. Dx tongue cancer 8/31/12. ok now. blog mausmarrow.com
|